Processa Pharmaceuticals, Inc. financial data

Symbol
PCSA on Nasdaq
Industry
Pharmaceutical Preparations
Location
7380 Coca Cola Drive, Suite 106, Hanover, Maryland
State of incorporation
Delaware
Fiscal year end
December 31
Former names
Heatwurx, Inc. (to 10/20/2017)
Latest financial report
10-Q - Q1 2024 - May 10, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 981 % +27.8%
Debt-to-equity 12.3 % +5.6%
Return On Equity -130 % +36.7%
Return On Assets -116 % +37%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 2.86 M shares -88.4%
Common Stock, Shares, Outstanding 2.86 M shares -88.4%
Entity Public Float 10.2 M USD -69.8%
Common Stock, Value, Issued 286 USD -88.4%
Weighted Average Number of Shares Outstanding, Basic 2.47 M shares +117%
Weighted Average Number of Shares Outstanding, Diluted 2.47 M shares +117%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 0 USD
Research and Development Expense 2.04 M USD +38.5%
General and Administrative Expense 4.45 M USD -55.7%
Operating Income (Loss) -10.2 M USD +64.2%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -25.7 M USD -72.7%
Net Income (Loss) Attributable to Parent -9.83 M USD +65.2%
Earnings Per Share, Basic -6.06 USD/shares +83.8%
Earnings Per Share, Diluted -6.06 USD/shares +68.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 8.92 M USD -17%
Assets, Current 9.8 M USD -19.8%
Property, Plant and Equipment, Net 2.42 K USD
Operating Lease, Right-of-Use Asset 146 K USD -35.8%
Intangible Assets, Net (Excluding Goodwill) 7.47 M USD -9.55%
Other Assets, Noncurrent 173 K USD -97.8%
Assets 9.94 M USD -20%
Accounts Payable, Current 455 K USD +43.8%
Accrued Liabilities, Current 466 K USD -70.4%
Liabilities, Current 1.01 M USD -53.2%
Operating Lease, Liability, Noncurrent 44.6 K USD -65.5%
Liabilities 1.06 M USD -53.7%
Retained Earnings (Accumulated Deficit) -78.1 M USD -14.4%
Stockholders' Equity Attributable to Parent 8.88 M USD -12.4%
Liabilities and Equity 9.94 M USD -20%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.05 M USD +3.08%
Net Cash Provided by (Used in) Financing Activities 6.26 M USD -1.4%
Common Stock, Shares Authorized 100 M shares +100%
Common Stock, Shares, Issued 2.86 M shares -88.4%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 4.21 M USD -0.56%
Deferred Tax Assets, Valuation Allowance 17.6 M USD +21.3%
Deferred Tax Assets, Gross 17.6 M USD +21.3%
Operating Lease, Liability 129 K USD -38.5%
Depreciation 139 USD
Lessee, Operating Lease, Liability, to be Paid 138 K USD -40.6%
Operating Lease, Liability, Current 84.9 K USD +4.57%
Lessee, Operating Lease, Liability, to be Paid, Year Two 70 K USD -24.2%
Lessee, Operating Lease, Liability, to be Paid, Year One 70 K USD -24.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 8.82 K USD -60.8%
Lessee, Operating Lease, Liability, to be Paid, Year Three 70 K USD +4398%
Preferred Stock, Shares Issued 0 shares
Unrecognized Tax Benefits 0 USD
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 197 K USD +0.73%